Vivanos Health

Name: Vivanos Health
Author: Vivanos Health, Inc.

By: Vivanos Health, Inc.

Diabetes management app for use by Primary Care Providers for their patients.

Features & Capabilities

Disclaimer
The use of this app is for informational purposes only and should not and cannot serve as a substitute for an examination and treatment by a qualified health care provider. Each person’s condition and situation is unique and individuals should consult a qualified health care provider for medical advice and answers to personal health questions. While this app attempts to be as accurate as possible, it should not be relied upon as being comprehensive or error-free.

Citations

Standards of Medical Care in Diabetes: Summary of Revisions.
DIABETES CARE 2022;45
https://diabetesjournals.org/care/article/45/Supplement_1/S4/138912/Summary-of-Revisions-Standards-of-Medical-Care-in

The Effect of Intensive Blood Glucose Control with Metformin on Complications in Overweight Patients with Type 2 Diabetes (UKPDS 34).
LANCET 1998;352:854.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(98)07037-8/fulltext

Efficacy of Atenolol and Captopril in Reducing Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes (UKPDS 39).
BR MED J 1998; 317:713.
https://pubmed.ncbi.nlm.nih.gov/9732338/

Glycemic Control with Diet, Sulfonylurea, Metformin, or Insulin in Patients with Type 2 Diabetes Mellitus: Progressive Requirement for Multiple Therapies (UKPDS 49).
JAMA 1999: 281:2005.
https://jamanetwork.com/journals/jama/fullarticle/190204

Intensive Blood Glucose Control with Sulfonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33).
Lancet 1998; 352:837.
https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(98)07019-6.pdf

Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes (UKPDS 38).
BMJ 1998; 317:703.
https://pubmed.ncbi.nlm.nih.gov/9732337/

DCCT Research Group: The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus.
N ENGL J MED 1993; 329:977.
https://www.nejm.org/doi/full/10.1056/nejm199309303291401